GenoITS

GenoITS is a computational tool that implements the regulatory workflow proposed under REACH for assessing the genotoxicity of chemicals.

QSAR models in GenoITS

In vitro gene mutation study in bacteria (Ames test)

REACH code: 8.4.1

In vitro mammalian chromosomal aberration study

REACH code: 8.4.2

In vitro gene mutation study in mammalian cells (Hprt assay)

REACH code: 8.4.3

In vivo mammalian somatic cell genotoxicity study (micronucleus assay)

REACH code: 8.4.4

In vivo mammalian somatic cell genotoxicity study (comet assay)

REACH code: 8.4.4

GenoITS is a computational workflow focused on the prediction of genotoxicity using the Integrated Testing Strategy proposed by REACH.

GenoITS uses 5 different QSAR models to perform the complete workflow, one per each kind of study demanded by REACH (gene mutation in bacteria; in vitro cytogenicity; in vitro gene mutation; in vivo cytogenicity; in vivo gene mutation). GenoITS also allows the users to supply their own experimental data.

REACH develops ITS for different properties aiming to reduce the number of experiments needed to perform an assessment. REACH also promotes alternative methods for the hazard assessment of substances in order to reduce the number of tests on animals.

Verify whether the molecules fall within the applicability domain (AD) of the models.
This operation does not consume any tokens.

VERIFY

If you use GenoITS in a publication, please cite the following reference:

Vallés-Pardo, J.L., Serrano-Candelas, E., Goya-Jorge, A., Moncho, S., Crespo, M., Macmillan, D.S., Gozalbes, R. (2025). GenoITS: Implementation of an Integrated Testing Strategy workflow for genotoxicity using QSAR-based tools. NAM Journal, 1, 100005.

https://doi.org/10.1016/j.namjnl.2024.100005

Download citation (BibTeX)

GenoITS was developed as a part of the GenoQSAR research project (https://protoqsar.com/genoqsar/). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101030422.